Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
LB939 Intravenous golimumab for hidradenitis suppurativa ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
LB939 Intravenous golimumab for hidradenitis suppurativa is a safe and effective replacement after infliximab anaphylaxis or loss of efficacy due to neutralizing antibodies
0
Authors
Eden Axler
2 more
Eden Axler
•
P.Y. Ch'en
•
Steven Cohen
Published
August 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The journal of investigative dermatology/Journal of investigative dermatology
Topics
Medicine
Epidemiology
Immunology
Dermatology
Internal Medicine
Show all topics
DOI
10.1016/j.jid.2024.06.1112
